Meningococcal vaccine trial for healthy adults 19 to 55 years old
Part of Infections clinical trials.
This trial tests a new meningococcal conjugate vaccine (EG-MCV4) in healthy adults to see how well the body's immune system responds and if it's safe. If you qualify, you'd help researchers learn if this vaccine can prevent meningococcal disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 19 and 55 years old.
- You are generally healthy and do not have any serious medical conditions.
- You have not had a meningococcal vaccine before.
- You are not pregnant or breastfeeding, and you use birth control if needed.
- You are willing to come to all study visits and follow the rules.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how safe and how well the body’s immune system responds to meningococcal and pneumococcal vaccines in adults living with HIV. It may help confirm these vaccines work properly and are safe for people on HIV treatment.
This trial tests a new meningitis vaccine (GNG-DE) to see how well it works compared to a vaccine already on the market. It might help protect you or your child from meningococcal disease.
This study tests a new vaccine that may protect against several types of meningococcal bacteria, which can cause serious infections like meningitis. It is given as a single shot to healthy people aged 2 to 59 years.
This study tests an experimental vaccine to protect babies and toddlers from meningitis (a serious infection of the brain and spinal cord). It checks how well the vaccine works and how safe it is in young children.
This study tests whether a new vaccine safely protects infants aged 6 to 11 months against four types of meningococcal bacteria that can cause serious infections like meningitis and blood infections. It is designed for healthy babies who have not yet received any meningococcal vaccine.
This trial tests a vaccine that protects against four types of meningococcal bacteria (groups A, C, W, and Y) in healthy babies aged 3 to 5 months. The vaccine is given to help prevent meningitis and other serious infections.
Hear when a new Meningococcal Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.